• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Fibrosarcoma

Fibrosarcoma - 21 Studies Found

Completed : Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
:
  • Adult Angiosarcoma
  • Adult Desmoplastic Small Round Cell Tumor
  • Biological: Cixutumumab Given

Completed : Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate
: Cancer
: 2010-01-11
:
  • Drug: Imatinib mesylate, Cyclophosphamide (Dosing level 1 )

Completed : Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
:
  • Adult Malignant Fibrous Histiocytoma of Bone
  • Desmoid Tumor
  • : 2007-05-16
    : Drug: sunitinib malate
Withdrawn : Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma
:
  • Childhood Malignant Fibrous Histiocytoma of Bone
  • Sarcoma

: 2006-06-07
:
  • Drug: glutamine
  • Procedure: chemoprotection

Completed : Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
: Life Threatening Diseases
: 2005-09-09
: Drug: Imatinib mesylate
Terminated : Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
: Sarcoma
: 2003-11-04
:
  • Biological: dactinomycin Given

Completed : Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma
:
  • Liposarcoma
  • Leiomyosarcoma
  • Fibrosarc
    : 2006-11-15
    : Drug: Sunitinib Malate (SU011248) For each 6 week cycle, patients will take SU011248 every day in the mo
Completed : Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers
:
  • Wilms Tumor
  • Fibrosarcoma
  • Carc
    : 2005-08-31
    :
    • Procedure: Myeloablative Chemotherapy

Completed : Bevacizumab and Radiation Therapy for Sarcomas
:
  • Soft Tissue Sarcoma
  • Fibrous Histiocytoma
  • Liposarcoma

  • : 2006-07-21
    :
    • Drug: Bevacizumab Bevacizumab

Completed : Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung
:
  • Osteosarcoma
  • Ewing Sarcoma Family Tumors
  • Malignant Fibrous
    : 2007-07-16
    : Biological: REOLYSIN® REOLYSIN® is given intravenously at a dose of 3x10E10 TCID50 over 60 min
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.